|
OMIM |
Link |
Information gain |
01 |
|
lymphangiectasia, intestinal
|
[NCBI]
|
0.00162298
|
|
|
immune defect due to absence of thymus
|
[NCBI]
|
0.0015281
|
|
|
PCD
|
[NCBI]
|
0.00145259
|
|
|
MBL2
|
[NCBI]
|
0.00129968
|
|
|
VRNI
|
[NCBI]
|
0.000973319
|
|
|
AFP
|
[NCBI]
|
0.000650077
|
|
|
RA
|
[NCBI]
|
0.000193819
|
|
|
CD22
|
[NCBI]
|
0.000179137
|
|
|
REG3A
|
[NCBI]
|
0.00016595
|
|
|
CDG2A
|
[NCBI]
|
0.000162824
|
|
|
KRT7
|
[NCBI]
|
0.000158508
|
|
|
HPS
|
[NCBI]
|
0.00015298
|
|
|
lymphoblastic transformation, inhibition of
|
[NCBI]
|
0.000138141
|
|
|
acid phosphatase deficiency
|
[NCBI]
|
0.000138141
|
|
|
lymphoblastic transformation, intrinsic defect in
|
[NCBI]
|
0.000138141
|
|
|
lymphoid system deterioration, progressive
|
[NCBI]
|
0.000138141
|
|
|
monocyte chemotactic disorder
|
[NCBI]
|
0.000138141
|
|
|
LGALS9
|
[NCBI]
|
0.000129631
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
0.000120719
|
|
|
FCN1
|
[NCBI]
|
0.000116246
|
|
|
CD209
|
[NCBI]
|
0.000108984
|
|
|
immunodeficiency, x-linked, with deficiency of 115,000 dalton surface glycoprotein
|
[NCBI]
|
0.000106602
|
|
|
CLEC4A
|
[NCBI]
|
0.00010407
|
|
|
SN
|
[NCBI]
|
9.91329e-05
|
|
|
PLDN
|
[NCBI]
|
9.72108e-05
|
|
|
SIGLEC10
|
[NCBI]
|
9.72108e-05
|
|
|
SIGLEC9
|
[NCBI]
|
9.72108e-05
|
|
|
CLEC4C
|
[NCBI]
|
9.72108e-05
|
|
|
SIGLEC8
|
[NCBI]
|
9.72108e-05
|
|
|
immunodeficiency with defective leukocyte and lymphocyte function and with response to histamine-1 antagonist
|
[NCBI]
|
9.47316e-05
|
|
|
KLRG1
|
[NCBI]
|
8.51783e-05
|
|
|
SIGLEC5
|
[NCBI]
|
8.51783e-05
|
|
|
SCGF
|
[NCBI]
|
8.31885e-05
|
|
|
MASP2
|
[NCBI]
|
7.92163e-05
|
|
|
LGALS2
|
[NCBI]
|
7.92163e-05
|
|
|
RTD
|
[NCBI]
|
7.30379e-05
|
|
|
schindler disease, type i
|
[NCBI]
|
7.30379e-05
|
|
|
GFAP
|
[NCBI]
|
7.14936e-05
|
|
|
APC
|
[NCBI]
|
7.05413e-05
|
|
|
CDGG1
|
[NCBI]
|
6.98243e-05
|
|
|
MAG
|
[NCBI]
|
6.94057e-05
|
|
|
KLRC1
|
[NCBI]
|
6.89327e-05
|
|
|
ITLN2
|
[NCBI]
|
6.47988e-05
|
|
|
LMAN2L
|
[NCBI]
|
6.47988e-05
|
|
|
SIGLEC11
|
[NCBI]
|
6.47988e-05
|
|
|
FCN2
|
[NCBI]
|
6.47988e-05
|
|
|
LMAN2
|
[NCBI]
|
6.47988e-05
|
|
|
aryl hydrocarbon hydroxylase inducibility
|
[NCBI]
|
6.4537e-05
|
|
|
SLE
|
[NCBI]
|
6.29796e-05
|
|
|
CDA
|
[NCBI]
|
6.23074e-05
|
|
|
TRPV1
|
[NCBI]
|
5.91419e-05
|
|
|
CLEC4M
|
[NCBI]
|
5.83969e-05
|
|
|
PTH
|
[NCBI]
|
5.58443e-05
|
|
|
WAS
|
[NCBI]
|
5.49064e-05
|
|
|
LGALS8
|
[NCBI]
|
5.45859e-05
|
|
|
MUC1
|
[NCBI]
|
5.44623e-05
|
|
|
CVID
|
[NCBI]
|
5.36645e-05
|
|
|
LGALS3
|
[NCBI]
|
5.21533e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
5.17861e-05
|
|
|
CEACAM5
|
[NCBI]
|
5.12675e-05
|
|
|
PRL
|
[NCBI]
|
5.04402e-05
|
|
|
ITLN1
|
[NCBI]
|
4.9977e-05
|
|
|
PSNP1
|
[NCBI]
|
4.98183e-05
|
|
|
galactose epimerase deficiency
|
[NCBI]
|
4.86714e-05
|
|
|
OMP
|
[NCBI]
|
4.7706e-05
|
|
|
KLRD1
|
[NCBI]
|
4.68169e-05
|
|
|
mucolipidosis iv
|
[NCBI]
|
4.65519e-05
|
|
|
hepatitis c virus, susceptibility to
|
[NCBI]
|
4.55687e-05
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
4.28751e-05
|
|
|
sialuria, finnish type
|
[NCBI]
|
4.28751e-05
|
|
|
THBS2
|
[NCBI]
|
4.2436e-05
|
|
|
amplified in osteosarcoma 9
|
[NCBI]
|
4.2436e-05
|
|
|
XPA
|
[NCBI]
|
4.04991e-05
|
|
|
EGFR
|
[NCBI]
|
4.02848e-05
|
|
|
C1QR1
|
[NCBI]
|
3.93582e-05
|
|
|
CLEC7A
|
[NCBI]
|
3.81035e-05
|
|
|
CSPG2
|
[NCBI]
|
3.69835e-05
|
|
|
NGFB
|
[NCBI]
|
3.63882e-05
|
|
|
MFGE8
|
[NCBI]
|
3.59722e-05
|
|
|
CLC
|
[NCBI]
|
3.59722e-05
|
|
|
AVP
|
[NCBI]
|
3.5763e-05
|
|
|
SELL
|
[NCBI]
|
3.50506e-05
|
|
|
OLR1
|
[NCBI]
|
3.42041e-05
|
|
|
FUT1
|
[NCBI]
|
3.26941e-05
|
|
|
CLEC10A
|
[NCBI]
|
3.23952e-05
|
|
|
GPR43
|
[NCBI]
|
3.23952e-05
|
|
|
SIGLECL1
|
[NCBI]
|
3.23952e-05
|
|
|
KLRF1
|
[NCBI]
|
3.23952e-05
|
|
|
BLOC1S2
|
[NCBI]
|
3.23952e-05
|
|
|
CLEC1B
|
[NCBI]
|
3.23952e-05
|
|
|
C2ORF30
|
[NCBI]
|
3.23952e-05
|
|
|
GPR42
|
[NCBI]
|
3.23952e-05
|
|
|
lectin, galactoside-binding, soluble, 12
|
[NCBI]
|
3.23952e-05
|
|
|
CLEC2B
|
[NCBI]
|
3.23952e-05
|
|
|
CLEC1A
|
[NCBI]
|
3.23952e-05
|
|
|
CDG1A
|
[NCBI]
|
3.16574e-05
|
|
|
BLM
|
[NCBI]
|
3.11925e-05
|
|
|
CF
|
[NCBI]
|
3.02223e-05
|
|
|
mucolipidosis ii
|
[NCBI]
|
2.90309e-05
|
|
|
RS1
|
[NCBI]
|
2.86764e-05
|
|
|
SMA1
|
[NCBI]
|
2.82343e-05
|
|
|
GDNF
|
[NCBI]
|
2.78866e-05
|
|
|
SDS
|
[NCBI]
|
2.7849e-05
|
|
|
KLRK1
|
[NCBI]
|
2.54539e-05
|
|
|
SNAPAP
|
[NCBI]
|
2.49843e-05
|
|
|
SFTPA2
|
[NCBI]
|
2.49843e-05
|
|
|
GPR41
|
[NCBI]
|
2.49843e-05
|
|
|
REG4
|
[NCBI]
|
2.49843e-05
|
|
|
SIGLEC6
|
[NCBI]
|
2.49843e-05
|
|
|
BLOC1S3
|
[NCBI]
|
2.49843e-05
|
|
|
CLEC4E
|
[NCBI]
|
2.49843e-05
|
|
|
MUTED
|
[NCBI]
|
2.49843e-05
|
|
|
KLRB1
|
[NCBI]
|
2.49843e-05
|
|
|
FCN3
|
[NCBI]
|
2.49843e-05
|
|
|
LGALS4
|
[NCBI]
|
2.49843e-05
|
|
|
BCGF
|
[NCBI]
|
2.4406e-05
|
|
|
BDNF
|
[NCBI]
|
2.35673e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
2.32916e-05
|
|
|
VIM
|
[NCBI]
|
2.31976e-05
|
|
|
CNO
|
[NCBI]
|
2.2195e-05
|
|
|
LGALS7
|
[NCBI]
|
2.2195e-05
|
|
|
CD207
|
[NCBI]
|
2.2195e-05
|
|
|
CLEC2D
|
[NCBI]
|
2.2195e-05
|
|
|
MAN2A2
|
[NCBI]
|
2.2195e-05
|
|
|
KLRC3
|
[NCBI]
|
2.2195e-05
|
|
|
IL2
|
[NCBI]
|
2.10571e-05
|
|
|
COLEC12
|
[NCBI]
|
2.0388e-05
|
|
|
C1GALT1C1
|
[NCBI]
|
2.0388e-05
|
|
|
GPR40
|
[NCBI]
|
2.0388e-05
|
|
|
LGALS13
|
[NCBI]
|
2.0388e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
1.98248e-05
|
|
|
KLRC2
|
[NCBI]
|
1.90476e-05
|
|
|
SPA17
|
[NCBI]
|
1.90476e-05
|
|
|
CD69
|
[NCBI]
|
1.90476e-05
|
|
|
CD248
|
[NCBI]
|
1.90476e-05
|
|
|
NPY
|
[NCBI]
|
1.90044e-05
|
|
|
CRC
|
[NCBI]
|
1.8235e-05
|
|
|
VIP
|
[NCBI]
|
1.8122e-05
|
|
|
BLOC1S1
|
[NCBI]
|
1.7982e-05
|
|
|
CEL
|
[NCBI]
|
1.79227e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
1.76553e-05
|
|
|
FTD
|
[NCBI]
|
1.7203e-05
|
|
|
MASP1
|
[NCBI]
|
1.7098e-05
|
|
|
DGS
|
[NCBI]
|
1.66817e-05
|
|
|
PRG2
|
[NCBI]
|
1.56845e-05
|
|
|
LMAN1
|
[NCBI]
|
1.56845e-05
|
|
|
fabry disease
|
[NCBI]
|
1.52544e-05
|
|
|
LGALS1
|
[NCBI]
|
1.51009e-05
|
|
|
NES
|
[NCBI]
|
1.51009e-05
|
|
|
TYROBP
|
[NCBI]
|
1.45772e-05
|
|
|
ALPI
|
[NCBI]
|
1.45772e-05
|
|
|
Ss
|
[NCBI]
|
1.45772e-05
|
|
|
BSG
|
[NCBI]
|
1.44433e-05
|
|
|
AL-A1
|
[NCBI]
|
1.41023e-05
|
|
|
AD
|
[NCBI]
|
1.40801e-05
|
|
|
MPO
|
[NCBI]
|
1.3888e-05
|
|
|
ERBB4
|
[NCBI]
|
1.36682e-05
|
|
|
AEBP1
|
[NCBI]
|
1.36682e-05
|
|
|
CHIA
|
[NCBI]
|
1.36682e-05
|
|
|
SFTPD
|
[NCBI]
|
1.36682e-05
|
|
|
SFTPA1
|
[NCBI]
|
1.32685e-05
|
|
|
PAEP
|
[NCBI]
|
1.30715e-05
|
|
|
NAGA
|
[NCBI]
|
1.28983e-05
|
|
|
DTNBP1
|
[NCBI]
|
1.25537e-05
|
|
|
homocystinuria
|
[NCBI]
|
1.22962e-05
|
|
|
DDR1
|
[NCBI]
|
1.19289e-05
|
|
|
LTF
|
[NCBI]
|
1.19289e-05
|
|
|
TF
|
[NCBI]
|
1.19226e-05
|
|
|
KLK3
|
[NCBI]
|
1.18907e-05
|
|
|
THY1
|
[NCBI]
|
1.16439e-05
|
|
|
DEFA1
|
[NCBI]
|
1.13745e-05
|
|
|
TH
|
[NCBI]
|
1.11535e-05
|
|
|
FUT2
|
[NCBI]
|
1.11193e-05
|
|
|
ORM1
|
[NCBI]
|
1.0646e-05
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
1.0646e-05
|
|
|
IFNAR1
|
[NCBI]
|
1.0646e-05
|
|
|
HGF
|
[NCBI]
|
1.03596e-05
|
|
|
PI
|
[NCBI]
|
1.02369e-05
|
|
|
CHS
|
[NCBI]
|
1.01948e-05
|
|
|
IFNA1
|
[NCBI]
|
9.9081e-06
|
|
|
APOE
|
[NCBI]
|
9.78434e-06
|
|
|
VEGF
|
[NCBI]
|
9.64658e-06
|
|
|
ACHE
|
[NCBI]
|
9.29488e-06
|
|
|
RBP3
|
[NCBI]
|
8.65336e-06
|
|
|
HPX
|
[NCBI]
|
8.65336e-06
|
|
|
TIMP1
|
[NCBI]
|
8.23197e-06
|
|
|
TNF
|
[NCBI]
|
8.1065e-06
|
|
|
MICA
|
[NCBI]
|
8.09986e-06
|
|
|
MCP
|
[NCBI]
|
7.79093e-06
|
|
|
ASPA
|
[NCBI]
|
7.60765e-06
|
|
|
DES
|
[NCBI]
|
7.16542e-06
|
|
|
RELN
|
[NCBI]
|
6.96034e-06
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
6.96034e-06
|
|
|
DHFR
|
[NCBI]
|
6.36733e-06
|
|
|
TNFSF6
|
[NCBI]
|
6.29546e-06
|
|
|
BL
|
[NCBI]
|
6.14349e-06
|
|
|
A2M
|
[NCBI]
|
5.60792e-06
|
|
|
SPTA1
|
[NCBI]
|
5.60792e-06
|
|
|
ANG
|
[NCBI]
|
4.71795e-06
|
|
|
VCP
|
[NCBI]
|
4.60679e-06
|
|
|
B2M
|
[NCBI]
|
4.60679e-06
|
|
|
PCNA
|
[NCBI]
|
4.58953e-06
|
|
|
IL3
|
[NCBI]
|
4.49902e-06
|
|
|
BTK
|
[NCBI]
|
4.44636e-06
|
|
|
EPO
|
[NCBI]
|
4.31058e-06
|
|
|
AT
|
[NCBI]
|
4.26935e-06
|
|
|
MAP2
|
[NCBI]
|
4.10873e-06
|
|
|
F3
|
[NCBI]
|
3.98238e-06
|
|
|
LAT
|
[NCBI]
|
3.91515e-06
|
|
|
CD
|
[NCBI]
|
3.8501e-06
|
|
|
OPRM1
|
[NCBI]
|
3.53679e-06
|
|
|
TYR
|
[NCBI]
|
3.49744e-06
|
|
|
NRG1
|
[NCBI]
|
3.12996e-06
|
|
|
APOB
|
[NCBI]
|
2.86944e-06
|
|
|
CFTR
|
[NCBI]
|
2.6574e-06
|
|
|
TLR9
|
[NCBI]
|
2.6549e-06
|
|
|
ADA
|
[NCBI]
|
2.57165e-06
|
|
|
LPO
|
[NCBI]
|
2.08678e-06
|
|
|
STAT1
|
[NCBI]
|
2.06396e-06
|
|
|
POMC
|
[NCBI]
|
1.82336e-06
|
|
|
NGFR
|
[NCBI]
|
1.74805e-06
|
|
|
AGER
|
[NCBI]
|
1.57995e-06
|
|
|
CHAT
|
[NCBI]
|
1.48936e-06
|
|
|
PD
|
[NCBI]
|
1.34404e-06
|
|
|
temporal arteritis
|
[NCBI]
|
1.15633e-06
|
|
|
PEDF
|
[NCBI]
|
8.4786e-07
|
|
|
CJD
|
[NCBI]
|
7.23294e-07
|
|
|
ALB
|
[NCBI]
|
5.53896e-07
|
|
|
ACP5
|
[NCBI]
|
4.8564e-07
|
|
|
SOD2
|
[NCBI]
|
4.77349e-07
|
|
|
MBP
|
[NCBI]
|
4.13119e-07
|
|
|
CCK
|
[NCBI]
|
3.72167e-07
|
|
|
GNRH1
|
[NCBI]
|
2.96951e-07
|
|
|
MG
|
[NCBI]
|
2.68734e-07
|
|
|
AMH
|
[NCBI]
|
2.65707e-07
|
|
|
EGF
|
[NCBI]
|
2.44748e-07
|
|
|
FA
|
[NCBI]
|
2.36083e-07
|
|
|
HP
|
[NCBI]
|
1.91671e-07
|
|
|
SPP1
|
[NCBI]
|
1.76558e-07
|
|
|
ACE
|
[NCBI]
|
8.20803e-08
|
|
|
TG
|
[NCBI]
|
7.71709e-08
|
|
|
STAR
|
[NCBI]
|
7.6752e-08
|
|
|
GPI
|
[NCBI]
|
7.20164e-08
|
|
|
BCHE
|
[NCBI]
|
6.09073e-08
|
|
|
GAL
|
[NCBI]
|
4.83723e-08
|
|
|
ABCC1
|
[NCBI]
|
2.52509e-08
|
|
|
TPO
|
[NCBI]
|
2.1899e-08
|
|
|
OSM
|
[NCBI]
|
7.93948e-09
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
7.48484e-09
|
|
|
TTR
|
[NCBI]
|
4.11781e-09
|
|
|
PTK2
|
[NCBI]
|
8.72981e-11
|
|